Development and validation of the BMQ-AIR©: a screening tool for assessing patients’ treatment beliefs about switching to anti-inflammatory reliever (AIR) therapy

IntroductionDespite anti-inflammatory reliever (AIR) therapy now being the preferred treatment choice across all severities of asthma, many patients are still “attached” to their short-acting beta2-agonist (SABA) reliever, believing this to be the best way to control their asthma. To encourage indiv...

Descrizione completa

Dettagli Bibliografici

Autori principali:	Holly Foot, Amy Hai Yan Chan, Rob Horne
Natura:	Artigo
Lingua:	Inglês
Pubblicazione:	Frontiers Media S.A. 2024-06-01
Serie:	Frontiers in Pharmacology
Soggetti:	asthma anti-inflammatory reliever therapy reliever short-acting beta-2 agonists inhaled corticosteroid questionnaire
Accesso online:	https://www.frontiersin.org/articles/10.3389/fphar.2024.1351851/full
Tags:	Aggiungi Tag Nessun Tag, puoi essere il primo ad aggiungerne!!